Your browser doesn't support javascript.
loading
Assessing the reporting of harms in systematic reviews focused on platelet-rich plasma therapy: a cross-sectional analysis.
Ward, Shaelyn; Ezell, Kade; Wise, Audrey; Garrett, Morgan; Rucker, Brayden; Lestersmith, Drew; Emam, Mohammed; Vassar, Matt.
Afiliación
  • Ward S; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107, USA.
  • Ezell K; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107, USA.
  • Wise A; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107, USA.
  • Garrett M; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107, USA.
  • Rucker B; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107, USA.
  • Lestersmith D; Baylor Scott & White All Saints Medical Center, Fort Worth, TX 76104, USA.
  • Emam M; Department of Physical Medicine & Rehabilitation, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Vassar M; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107, USA.
Regen Med ; 18(7): 531-542, 2023 07.
Article en En | MEDLINE | ID: mdl-37340904
This study looked at how well the negative effects (harms) of platelet-rich plasma therapy are reported in systematic reviews (SRs). The researchers carefully reviewed and extracted data of SRs from different databases. They found that less than 50% of the SRs reported the harms associated with platelet rich plasma therapy. The researchers also used a tool called AMSTAR to assess the value of each of the SRs, and most were found to be 'critically low' reviews. In conclusion, this study highlights the importance of platelet rich plasma therapy negative effect reporting by SRs.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estudios Transversales Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Regen Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estudios Transversales Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Regen Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido